Status:
COMPLETED
Acupuncture as Migraine Prophylaxis in Reducing Frequency, Duration and Intensity of Migraine With Minimum Acupoint, Seen up to Eight Weeks From Baseline
Lead Sponsor:
Indonesia University
Conditions:
Migraine
Headache
Eligibility:
All Genders
19-50 years
Phase:
NA
Brief Summary
Migraine is a primary headache attack, specific, paroxysmal, with or without aura, with subjective manifestations both before and after the attack, a chronic type of headache with symptoms of recurren...
Detailed Description
Migraine is a primary headache attack, specific, paroxysmal, with or without aura, with subjective manifestations both before and after the attack, a chronic type of headache with symptoms of recurren...
Eligibility Criteria
Inclusion
- subjects aged 19-50 years
- subjects with history of clinical diagnosis of migraine (interictal period)
- signed research approval forms, and were willing to take the study to completion.
Exclusion
- subjects with pregnancy,
- lesions, wounds, infections and suffering from malignant diseases or tumor and thrombophlebitis in the area at the selected acupuncture point
- increasing liver function three times above normal values.
Key Trial Info
Start Date :
July 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04509141
Start Date
July 5 2019
End Date
August 30 2019
Last Update
August 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Indonesia
Jakarta Pusat, DKI Jakarta, Indonesia, 10440